Survival analyses for differences in time-to-event (years) by first-line management
Survival . | No. (%) . | Events . | Median OS or EFS (95% CI) . | 6-year OS or EFS (95% CI) . | P . |
---|---|---|---|---|---|
OS | |||||
All patients | 123 | 10 | NR | 0.93 (0.88-0.99) | .024 |
Active surveillance | 58 (47) | 6 | NR | 0.91 (0.81-1.00) | |
Surgical resection | 51 (41) | 1 | NR | 1.00 (1.00-1.00) | |
Systemic treatment | 14 (11) | 3 | NR | 0.76 (0.56-1.00) | |
EFS | |||||
All patients | 123 | 37 | 9.1 (7.7-NR) | 0.69 (0.59-0.79) | .013 |
Active surveillance | 58 (47) | 17 | 7.2 (6.8-NR) | 0.65 (0.51-0.83) | |
Surgical resection | 51 (41) | 12 | NR (12.8-NR) | 0.74 (0.62-0.90) | |
Systemic treatment | 14 (11) | 8 | 7.3 (1.8-NR) | 0.62 (0.40-0.95) |
Survival . | No. (%) . | Events . | Median OS or EFS (95% CI) . | 6-year OS or EFS (95% CI) . | P . |
---|---|---|---|---|---|
OS | |||||
All patients | 123 | 10 | NR | 0.93 (0.88-0.99) | .024 |
Active surveillance | 58 (47) | 6 | NR | 0.91 (0.81-1.00) | |
Surgical resection | 51 (41) | 1 | NR | 1.00 (1.00-1.00) | |
Systemic treatment | 14 (11) | 3 | NR | 0.76 (0.56-1.00) | |
EFS | |||||
All patients | 123 | 37 | 9.1 (7.7-NR) | 0.69 (0.59-0.79) | .013 |
Active surveillance | 58 (47) | 17 | 7.2 (6.8-NR) | 0.65 (0.51-0.83) | |
Surgical resection | 51 (41) | 12 | NR (12.8-NR) | 0.74 (0.62-0.90) | |
Systemic treatment | 14 (11) | 8 | 7.3 (1.8-NR) | 0.62 (0.40-0.95) |
P values correspond to Kaplan-Meier log-rank test.
NR, not reached.